SHA/600535 (SHA/600535)

Shanghai Stock Exchange: SHA/600535 · CNY

CN¥13.7

-0.02 (-0.1%)· Recorded snapshot

Market cap	20.4B
Revenue (ttm)	8B
Net income (ttm)	1.2B
EPS (ttm)	CN¥0.82
Shares out	1.5B
P/E (trailing)	16.7x
P/E (forward)	9.0x
Dividend	CN¥0.34 (2.48%)
Volume	11,892,180
Beta	0.21

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8B
Net income (ttm): 1.2B
EPS (ttm): CN¥0.82
P/E (trailing): 16.7x
P/E (forward): 9.0x
Market cap: 20.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E9

P25 n/aP50 n/aP75 n/a

Trailing P/E16.7

P25 n/aP50 n/aP75 n/a

ROE9

P25 n/aP50 n/aP75 n/a

ROIC14.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHA/600535 indicators

Market & fundamental data

Available fields

260

Groups with data

Currency

CNY

Showing 260 of 260 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-24
Employees	10,563
Employees change	-395
Employees growth	-3.6%
Enterprise value	CNY 17B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1994
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CNE000001C81
Last earnings date	2026-10-24
Last refreshed	2026-10-28
Last stock split date	2018-06-05
Last stock split type	Forward
Market cap	CNY 20.4B
Next earnings date	2026-11-03
Price	CNY 13.68
Price currency	CNY
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	sha/600535
Website	https://www.taslypharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	23.07x
Average P/E ratio (3Y)	21.05x
Average P/E ratio (5Y)	21.42x
Earnings yield	5.99%
EV/Earnings	13.96x
EV/EBIT	9.89x
EV/EBITDA	8.2x
EV/FCF	11.14x
EV/Sales	2.13x
FCF / EV yield	8.97%
FCF yield	7.49%
Forward P/E	8.95x
Graham number	12.62618
Graham upside	-7.7%
Industry forward P/E	18.72x
Industry P/E	33.27x
Lynch fair value	CNY 4.10
Lynch upside	-70.05%
P/B ratio	1.57x
P/E ratio	16.7x
P/FCF ratio	13.36x
P/OCF ratio	10.87x
P/S ratio	2.56x
Price / tangible book value	1.69x
Price/EBITDA ratio	10.2x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.58%
EBITDA margin	25.09%
Effective tax rate	21.03%
FCF margin	19.15%
Gross margin	67.84%
Operating margin	21.58%
Pretax margin	18.3%
Profit margin	15.29%
Profit per employee	CNY 115,797
Profitable quarters	18
Profitable years	3
Revenue per employee	CNY 757,309
ROA	7.19%
ROA (5Y)	5.31%
ROCE	12.87%
ROE	9.05%
ROE (5Y)	7.92%
ROIC	14.15%
ROIC (5Y)	10.88%
Tax / revenue	3.85%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	10.81%
EPS growth (Q)	0.97%
EPS growth (QoQ)	-59.5%
EPS growth 10Y	-0.19%
EPS growth 3Y	2.65%
EPS growth 5Y	-4.08%
EPS growth years	1
FCF growth	23.95%
FCF growth (Q)	-12.48%
FCF growth (QoQ)	-90.82%
FCF growth 3Y	-4.67%
FCF growth 5Y	-7.39%
Gross profit growth	-3.08%
Gross profit growth (Q)	-7.55%
Gross profit growth 3Y	-2.89%
Gross profit growth 5Y	0.69%
Net income growth	11.42%
Net income growth (Q)	0.1%
Net income growth (QoQ)	-59.83%
Net income growth 3Y	3.22%
Net income growth 5Y	-4.09%
Net income growth quarters	8
Net income growth years	1
OCF growth	10.9%
OCF growth (Q)	92.48%
OCF growth (QoQ)	-77.36%
OCF growth 10Y	9.51%
OCF growth 3Y	-6.29%
OCF growth 5Y	-7.23%
Operating income growth	35.48%
Operating income growth (Q)	51.28%
Operating income growth 3Y	0.65%
Operating income growth 5Y	13.54%
Revenue growth	-4.16%
Revenue growth (Q)	-7.41%
Revenue growth (QoQ)	-8.04%
Revenue growth 10Y	-5.07%
Revenue growth 3Y	-4.12%
Revenue growth 5Y	0.11%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -350.1M
Depreciation and amortization	CNY 280.9M
EBIT	CNY 1.7B
EBITDA	CNY 2B
EPS	CNY 0.82
FCF per share	CNY 1.03
Financing cash flow	CNY -1.2B
Free cash flow	CNY 1.5B
Gross profit	CNY 5.4B
Income taxes	CNY 307.7M
Investing cash flow	CNY -945.2M
Net borrowing	CNY -443.2M
Net cash flow	CNY -246.3M
Net income	CNY 1.2B
Operating income	CNY 1.7B
Revenue	CNY 8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	9.01
Book value per share	CNY 8.65
Debt / EBITDA	0.09
Debt / equity	0.01
Debt / FCF	0.12
Interest coverage	53.12
Long-term assets	CNY 7B
Long-term liabilities	CNY 365.3M
Net cash (debt)	CNY 3.5B
Net cash / market cap	17.19%
Net cash growth	33.64%
Net debt / EBITDA	-1.75
Net debt / equity	-0.27
Net debt / FCF	-2.3
Piotroski F-Score	8
Property, plant and equipment	CNY 3.4B
Shareholders' equity	CNY 13B
Tangible book value	CNY 12.1B
Tangible book value per share	CNY 8.11
Total assets	CNY 15.1B
Total cash	CNY 3.7B
Total debt	CNY 182.4M
Total liabilities	CNY 2B
WACC	5.47%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.53
Current assets	CNY 8.1B
Current liabilities	CNY 1.7B
Current ratio	4.86
Inventory turnover	1.83
Net working capital	CNY 2.7B
Quick ratio	3.94
Working capital	CNY 6.4B
Working capital turnover	1.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.55%
Dividend growth	-17.07%
Dividend growth (10Y)	1.26%
Dividend growth (3Y)	1%
Dividend growth (5Y)	0.6%
Dividend growth years	0
Dividend payment date	2026-10-15
Dividend payment years	24
Dividend payout frequency	Semi-Annual
Dividend per share	CNY 0.34
Dividend yield	2.49%
Ex-dividend date	2026-10-15
FCF payout ratio	33.15%
Last dividend	CNY 0.24
Payout ratio	38.33%
Shareholder yield	1.93%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-52.96%
10Y return CAGR	-5.03%
10Y total return	-40.28%
150-day SMA	CNY 14.49
15Y price change	-7.3%
15Y return CAGR	1.42%
15Y total return	23.54%
1D price change	-0.15%
1M total return	1.71%
1W price change	-3.05%
1W total return	-3.05%
1Y price change	-11.63%
1Y return CAGR	-9.47%
1Y total return	-9.46%
20-day SMA	CNY 13.96
200-day SMA	CNY 14.58
20Y price change	324.71%
20Y return CAGR	9.88%
20Y total return	557.73%
3M price change	-14.07%
3M total return	-12.6%
3Y price change	-5.2%
3Y return CAGR	1.43%
3Y total return	4.34%
50-day SMA	CNY 14.37
50-day SMA vs 200-day SMA	50under200
52-week high	CNY 16.24
52-week high date	2026-07-20
52-week low	CNY 12.90
52-week low date	2026-06-29
5Y price change	0.81%
5Y return CAGR	3.2%
5Y total return	17.07%
6M price change	-8.68%
6M total return	-6.44%
All-time high	CNY 41.32
All-time high date	2015-05-27
All-time low	CNY 1.90
All-time low date	2004-07-27
Average true range (ATR)	CNY 0.30
Average volume	12.7M
Beta (1Y)	-0.05
Beta (2Y)	0.08
Beta (5Y)	0.21
Change from 52-week high	-15.76%
Change from 52-week low	6.05%
Change from all-time high	-66.89%
Change from all-time low	618.49%
Change from open	-0.36%
Day's gap	0.22%
Dollar volume	CNY 162.7M
High price	CNY 13.90
Low price	CNY 13.65
Monthly RSI	44.79
Open price	CNY 13.73
Position in 52-week range	12%
Previous close	CNY 13.70
Price vs 150-day SMA	-5.58%
Price vs 20-day SMA	-1.99%
Price vs 200-day SMA	-6.17%
Price vs 50-day SMA	-4.81%
Relative volume	0.94
RSI	40.61
Sharpe ratio	-0.65
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	0.16
Sortino ratio	-0.68
Sortino ratio (3Y)	0.35
Sortino ratio (5Y)	0.44
Volume	11.9M
Weekly RSI	39.71
YTD price change	-9.22%
YTD total return	-7%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	736.8M
Shares change (QoQ)	-0.79%
Shares change (YoY)	0.55%
Shares held by institutions	6.56%
Shares outstanding	1.5B

Deeper analysis on SHA/600535

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHA/600535 report

Is a complete SHA/600535 research report available?

No complete published report is available for sha/600535 (SHA/600535) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHA/600535 (SHA/600535)

Price

Financial snapshot

Fair-value bridge

Latest news · SHA/600535

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHA/600535 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHA/600535

Frequently asked questions